North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow at a CAGR of 5.1% from 2022 to 2028.
Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry Fuels North America Clinical Trials Market
The pharmaceutical industry is one of the most R&D-intensive industries globally. The value of medicines is becoming increasingly important as pharmaceutical companies are keen to ensure that R&D achieves their intended goal. Over the last decade, the number of new drugs approved yearly has also increased. Efforts are being made to achieve greater effectiveness and efficiency in fulfilling patients' needs. The US is a leading country in R&D investments, producing over half of the world’s new molecules in the past decade. The US accounted for 62.3% of sales of new medicines launched during 2014–2019. R&D is a significant and essential part of the business of pharmaceutical companies as it enables them to come up with new molecules for various therapeutic applications with significant medical and commercial potential.
R&D expenditure is done to discover, examine, and produce new products; upfront payments; improve existing outcomes; and demonstrate product efficacy and regulatory compliance before launch. The R&D investments differ as per the need and demand for clinical trials. The cost includes materials, supplies used, and salaries, along with the cost of developing quality control.
North America Clinical Trials Market Overview
The North America clinical trials market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trials. The market growth in the region is accredited to the US emerging as a leading clinical research destination and the innovative services offered by companies for applications in clinical trials.
The US has emerged as a leading clinical research destination. Nearly half of the total clinical trials are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial generated data globally. A World Health Organization (WHO) report states that the US registered the highest number of clinical trials (157,618) in 2021.
North America clinical Trials Market Revenue and Forecast to 2028 (US$ Million)
North America Clinical Trials Market Segmentation
The North America clinical trials market is segmented into phase, study design, indication, and country.
Based on phase, the North America clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest North America clinical trials market share in 2022.
Based on study design, the North America clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest North America clinical trials market share in 2022.
Based on Indication, the North America clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest North America clinical trials market share in 2022.
Based on country, the North America clinical trials market has been categorized into the US, Canada, and Mexico. The US dominated the North America clinical trials market share in 2022.
Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the North America clinical trials market.
Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry Fuels North America Clinical Trials Market
The pharmaceutical industry is one of the most R&D-intensive industries globally. The value of medicines is becoming increasingly important as pharmaceutical companies are keen to ensure that R&D achieves their intended goal. Over the last decade, the number of new drugs approved yearly has also increased. Efforts are being made to achieve greater effectiveness and efficiency in fulfilling patients' needs. The US is a leading country in R&D investments, producing over half of the world’s new molecules in the past decade. The US accounted for 62.3% of sales of new medicines launched during 2014–2019. R&D is a significant and essential part of the business of pharmaceutical companies as it enables them to come up with new molecules for various therapeutic applications with significant medical and commercial potential.
R&D expenditure is done to discover, examine, and produce new products; upfront payments; improve existing outcomes; and demonstrate product efficacy and regulatory compliance before launch. The R&D investments differ as per the need and demand for clinical trials. The cost includes materials, supplies used, and salaries, along with the cost of developing quality control.
North America Clinical Trials Market Overview
The North America clinical trials market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trials. The market growth in the region is accredited to the US emerging as a leading clinical research destination and the innovative services offered by companies for applications in clinical trials.
The US has emerged as a leading clinical research destination. Nearly half of the total clinical trials are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial generated data globally. A World Health Organization (WHO) report states that the US registered the highest number of clinical trials (157,618) in 2021.
North America clinical Trials Market Revenue and Forecast to 2028 (US$ Million)
North America Clinical Trials Market Segmentation
The North America clinical trials market is segmented into phase, study design, indication, and country.
Based on phase, the North America clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest North America clinical trials market share in 2022.
Based on study design, the North America clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest North America clinical trials market share in 2022.
Based on Indication, the North America clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest North America clinical trials market share in 2022.
Based on country, the North America clinical trials market has been categorized into the US, Canada, and Mexico. The US dominated the North America clinical trials market share in 2022.
Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the North America clinical trials market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Clinical Trials Market – By Phase
1.3.2 North America Clinical Trials Market – By Study Design
1.3.3 North America Clinical Trials Market – By Indication
1.3.4 North America Clinical Trials Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA CLINICAL TRIALS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. NORTH AMERICA CLINICAL TRIALS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6. CLINICAL TRIALS MARKET – NORTH AMERICA ANALYSIS
6.1 North America Clinical Trials Market Revenue Forecast and Analysis
7. NORTH AMERICA CLINICAL TRIALS MARKET REVENUE AND FORECAST TO 2028 – BY STUDY DESIGN
7.1 Overview
7.2 North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
7.3.1 Overview
7.3.2 Interventional: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
7.4.1 Overview
7.4.2 Observational: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
7.5.1 Overview
7.5.2 Expanded Access: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA CLINICAL TRIALS MARKET – BY PHASE
8.1 Overview
8.2 North America Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
8.3.1 Overview
8.3.2 Phase III: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
8.4.1 Overview
8.4.2 Phase II: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
8.5.1 Overview
8.5.2 Phase IV: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
8.6.1 Overview
8.6.2 Phase I: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA CLINICAL TRIALS MARKET REVENUE AND FORECAST TO 2028 – INDICATION
9.1 Overview
9.2 North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
9.3.1 Overview
9.3.2 Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
9.4.1 Overview
9.4.2 Pain Management: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
9.6.1 Overview
9.6.2 CNS Condition: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
9.7.1 Overview
9.7.2 Diabetes: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
9.8.1 Overview
9.8.2 Obesity: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
9.9.1 Overview
9.9.2 Cardiovascular: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.10 Other
9.10.1 Overview
9.10.2 Other: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA CLINICAL TRIALS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 North America: Clinical Trials Market
10.1.1 Overview
10.1.2 North America: Clinical Trials Market, by Country, 2022& 2028 (%)
10.1.2.1 US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.1.4 US: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.1.5 US: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.2 Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.2.4 Canada: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.2.5 Canada: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.3 Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.3.4 Mexico: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.3.5 Mexico: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 IQVIA Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Parexel International Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 IXICO Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 ICON Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 SGS SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Syneos Health Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Clinical Trials Market – By Phase
1.3.2 North America Clinical Trials Market – By Study Design
1.3.3 North America Clinical Trials Market – By Indication
1.3.4 North America Clinical Trials Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA CLINICAL TRIALS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. NORTH AMERICA CLINICAL TRIALS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6. CLINICAL TRIALS MARKET – NORTH AMERICA ANALYSIS
6.1 North America Clinical Trials Market Revenue Forecast and Analysis
7. NORTH AMERICA CLINICAL TRIALS MARKET REVENUE AND FORECAST TO 2028 – BY STUDY DESIGN
7.1 Overview
7.2 North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
7.3.1 Overview
7.3.2 Interventional: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
7.4.1 Overview
7.4.2 Observational: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
7.5.1 Overview
7.5.2 Expanded Access: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA CLINICAL TRIALS MARKET – BY PHASE
8.1 Overview
8.2 North America Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
8.3.1 Overview
8.3.2 Phase III: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
8.4.1 Overview
8.4.2 Phase II: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
8.5.1 Overview
8.5.2 Phase IV: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
8.6.1 Overview
8.6.2 Phase I: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA CLINICAL TRIALS MARKET REVENUE AND FORECAST TO 2028 – INDICATION
9.1 Overview
9.2 North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
9.3.1 Overview
9.3.2 Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
9.4.1 Overview
9.4.2 Pain Management: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
9.6.1 Overview
9.6.2 CNS Condition: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
9.7.1 Overview
9.7.2 Diabetes: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
9.8.1 Overview
9.8.2 Obesity: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
9.9.1 Overview
9.9.2 Cardiovascular: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.10 Other
9.10.1 Overview
9.10.2 Other: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA CLINICAL TRIALS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 North America: Clinical Trials Market
10.1.1 Overview
10.1.2 North America: Clinical Trials Market, by Country, 2022& 2028 (%)
10.1.2.1 US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.1.4 US: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.1.5 US: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.2 Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.2.4 Canada: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.2.5 Canada: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.3 Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.3.4 Mexico: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.3.5 Mexico: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 IQVIA Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Parexel International Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 IXICO Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 ICON Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 SGS SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Syneos Health Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms
Table 1. US Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Clinical Trials Market Segmentation
Figure 2. North America Clinical Trials Market, By Country
Figure 3. North America Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in North America Clinical Trials Market
Figure 5. Canada is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Experts Opinion
Figure 8. Impact Analysis
Figure 9. North America Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)
Figure 29. North America: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
Figure 1. North America Clinical Trials Market Segmentation
Figure 2. North America Clinical Trials Market, By Country
Figure 3. North America Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in North America Clinical Trials Market
Figure 5. Canada is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Experts Opinion
Figure 8. Impact Analysis
Figure 9. North America Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)
Figure 29. North America: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
